Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Qian (Cambridge, United Kingdom), K. Lee (Cambridge, United Kingdom), E. Palas (Cambridge, United Kingdom), S. George (Cambridge, United Kingdom), Y. Huang (Cambridge, United Kingdom), S. Rahman (Cambridge, United Kingdom), N. Li (Cambridge, United Kingdom), D. Wong (Cambridge, United Kingdom), M. Mason (Cambridge, United Kingdom), I. Smith (Cambridge, United Kingdom). Does chronic opioid use impact OSA diagnosis and response to treatment with CPAP?. 2152

Member's Comments

No comment yet.

Related content which might interest you: Enough is enough: misuse of NIV in the treatment of chronic patients with exacerbation of symptoms? Source: Annual Congress 2013 –The dark side of the moon: when, why, and where I should not use NIV? Year: 2013 Effect of CPAP adherence on depression in OSA patient Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Peculiar properties of sleep structure and impact of antidepressive therapy in COPD patients with concomitant depressive episode Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Does CPAP use reflect effective CPAP treatment? Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 Does chronic opioid therapy alter the pattern of sleep apnea? Source: Eur Respir J 2004; 24: Suppl. 48, 446s Year: 2004 Do beta-blockers reduce sympathetic activity in patients with mild sleep breathing disorder without CPAP therapy? Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 May the obesity cause a better prognosis for domiciliary NIV prescribed COPD patients? Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure Year: 2015 Does the choice of ICS/LABA regimen influence exacerbation rates in asthma patients with high as-needed use? Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma Year: 2007 Effects of CPAP treatment on anxiety and depression in patients with OSAS Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Clinical implications of residual sleep apnoea after chronic CPAP therapy Source: Breathe 2011; 7: 289-290 Year: 2011 Effects of an eHealth intervention promoting correct use of medication in patients with asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 CPAP therapy impact in OSA related symptoms – a prospective study Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2011; 39: 226-227 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2012; 39: 226-227 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2011; 39: 227-228 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2012; 39: 227-228 Year: 2012 Self efficacy treatment: how health belief model can influence CPAP compliance in OSAS. Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019